The procedure offers direct access to the most common origin of breast cancer, the milk ducts, and could be used to develop cancer therapy that spares healthy regions of the body, scientists say.
"Local delivery of therapeutic agents into the breast, through intra-nipple injection, could diminish the side effects typically observed with systemic chemotherapy - where the toxic drugs pass through all of the tissues of the body," said Dr Silva Krause, one of the researchers behind the experiment.
"It also prevents drug breakdown by the liver, for example, which can rapidly reduce effective drug levels," Krause said.
"The authors have utilised this technique to inject a new nanoparticle-based therapeutic that inhibits a specific gene that drives breast cancer formation," said Silva.
"This targeted treatment was shown to prevent cancer progression in mice that spontaneously develop mammary tumours, and is currently in review in Science Translational Medicine," she said.
The study was published in the Journal of Visualised Experiments.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
